The Hidden Cost of Going It Alone on GLP-1

Getting the prescription was the hardest part. Or so you thought.

You were probably sitting on the sidelines for a month or two, wondering if you should even talk to your doctor about this. Whether or not they’d think you were eligible for GLP-1. You fought through the insurance hurdle. Maybe you couldn’t even get insured for it. Maybe you just decided to pay out of pocket. And you finally got that first pen or first pill in your hand.

You took it. And then what?

Silence.

Nobody called to check in on you. Your telehealth provider just left you alone. Nobody told you what to expect. Nobody told you that the next day would bring nausea at eleven in the morning and that you’d be wiped out by four in the afternoon.

The truth is, getting the prescription is the easy part. What comes after is where most people struggle — and where the healthcare system starts to fade away.

Five Questions and a Shipping Notification

Here’s the uncomfortable truth about GLP-1 therapy: your prescriber wrote you a script. The pharmacy filled it. Nobody owns what happens after that.

If you’re like me, I never even got the chance to meet anyone before I got the prescription. I knew my insurance wasn’t going to cover it. So I went the more convenient route — I went online to one of the major retailers and booked an appointment.

Guess what happened when my time showed up? It was a message saying, Hey, take this five-question survey. And after I did that, I was given the prescription. That feeling of anxiety I had — the worry that I wasn’t going to qualify — it faded away. I was ecstatic. I was so happy I got the script.

The next message I got was: Your meds have been shipped. You should receive them in two days.

And then crickets. Crickets after that.

What am I supposed to do with these meds? Pop a pill once a day, they said. What should I expect? The only thing I had access to was a chat box. And nobody was responding. The only communication I had with my prescriber was twenty days later, when it was time to re-up my refill. And at that point, it was just a simple prompt on my screen asking if I wanted to increase my dosage.

I said yes. Because why not? Double the dose, double the result. What’s the worst that can happen?

Guess what I thought was going to happen? I thought I was going to get a chance to talk to the prescriber. Ask some questions. Get some actual guidance about what this higher dose would feel like, what to watch for, whether I should change anything about how I was eating or when I was taking it.

Guess what really happened? That’s right. You know it. I got the script and no one talked to me. Nothing but a number.

Telehealth providers now account for a huge share of GLP-1 prescriptions. They provide even less support than traditional clinics — and my story is the evidence. A recent industry survey found that 67% of primary care physicians believe telehealth GLP-1 prescribers may put patients’ health at risk. There are no standard protocols for resistance training or protein optimization with these providers. You get the script and you move on. You’re on your own for the rest.

The Cost of Silence

And here’s what the data shows about people who are left to figure it out alone: 30 to 37% quit within the first three months. Nearly half to two-thirds discontinue within a year. By the two-to-three year mark, only 14 to 15% are still on therapy.

Those aren’t just statistics. Each one is a person just like you and me who started with hope and walked away without the outcome they needed.

The costs of unsupported GLP-1 therapy aren’t always obvious. They accumulate quietly — in confusion, in anxiety, in outcomes that fall far short of what was possible.

Side effects without context

You wake up in the morning with nausea so intense you can barely move, wondering if you’re even going to make it through the work day. Is this normal? Is this what GLP-1 is supposed to do? Is this dangerous? Should I skip the next dose or keep going? What do I do about the nausea?

Without guidance, you don’t know. And that uncertainty isn’t just uncomfortable — it is detrimental to someone trying to commit to their weight loss journey. Side effects are the number one reason people stop GLP-1 therapy — accounting for 28.2% of all documented discontinuations. Not because every side effect is unbearable. Because nobody tells them what’s expected, what’s manageable, and what to actually do about it.

What a supported patient hears is: This is expected. Here’s what to eat. Here’s when it should ease. Here’s when to call your doctor. What an unsupported patient hears is nothing at all.

Plateaus without explanation

Somewhere around months three to six, the scale stops moving. For almost everyone. This is a well-documented, predictable phase of GLP-1 therapy. Your body has been losing weight. It’s been adjusting to this medication. It’s used to this new norm. The initial rapid weight loss starts to slow to a steadier pace — and your body is doing exactly what it’s supposed to do.

But if you’re in month three to six and nobody told you this was coming — and you and I both know we can’t get someone to pick up the phone — you’re going to interpret something completely normal as medication failure. You think the drug stopped working. You think you’re done. So you quit. You lost a good chunk of weight. You didn’t quite hit your goals. And you walked away at the beginning of your journey because nobody told you the middle was supposed to look like this.

The plateau wasn’t the problem. The silence was.

Muscle loss and hair loss without warning

One of the most consequential and least discussed costs: research on rapid weight loss shows that up to 39% of weight lost can be lean muscle mass. That matters enormously — your metabolism, your mobility, your strength, how you look and feel in your body. The solution is well-established: adequate protein and resistance training from day one. But nobody prescribes that alongside the medication. And by the time you notice you’ve lost muscle, you’ve already lost months of opportunity to prevent it.

Then there’s the hair loss. At month three, it starts falling out. Not a few strands — clumps. In the shower. On your pillow. You panic. You reach out to the person who prescribed the medication and guess what? Crickets. The difference between panic at month three and preparation at month one is information delivered at the right time.

Same Drug. Half the Results.

Here is the most telling statistic in all of GLP-1 therapy: real-world weight loss is approximately 50% of what clinical trials achieve. Patients in the real world average roughly half the weight loss on semaglutide compared to 15% or more in trials.

Same drug. Same doses. Half the results.

Think about the people who went through clinical trials. They came through with structured support. Regular check-ins. Dietary counseling. Exercise guidance. Side effect management. Someone who knew their name, their history, and their progress. Someone who reached out before the problems became a crisis.

That support isn’t a nice-to-have. It is the variable. It’s the single thing that separates the outcomes people hope for from the outcomes they actually get. And it’s the one thing that almost nobody on GLP-1 therapy in the real world has access to.

Where People Actually Go for Help

In the absence of clinical support, patients have built something remarkable — peer support networks that function as informal care systems. Facebook groups like Mounjaro Weight Loss Success have nearly a hundred thousand members. Reddit communities for every single one of the drugs are offering support to millions of people.

People aren’t going to Reddit because they want to. They’re going there because they have to. There is no other place to do it.

They crowdsource prior authorization appeals, share copay card strategies, warn each other about sulfur burps and hair loss, and talk each other through the anxiety of dose escalation. They’re doing the work that the healthcare system should be doing — with incomplete information, no clinical oversight, and the constant risk of bad advice.

The last thing anyone wants is to take their medical advice from Reddit. But when your prescriber is a chat box that nobody monitors, what choice do you have?

What Real Support Actually Looks Like

Real support on GLP-1 isn’t about having someone check in with you once a month. It’s not logging your weight. It’s not asking about your meals. It’s more fundamental than that.

It’s the feeling that someone knows what you’re going through and is paying attention. It’s daily guidance that adapts to where you are in your journey — not generic advice for everyone, but specific, timely direction based on your dose, your side effects, and where you are on this road. It’s a proactive alert at week eight telling you to start biotin because four weeks from now your hair might start thinning. It’s letting you know at week nine to start ramping up resistance training so your muscles don’t deteriorate. It’s telling you at month three that what looks like a plateau is normal — stick with it, the goal is within sight.

It’s someone — or something — that remembers your story. That knows you struggled with nausea the last time you had a dose increase and checks back in on you this time. That notices you haven’t logged protein in a week. That looks ahead at your timeline and prepares you for what’s coming next.

That’s the difference between tracking and guidance. Between recording what happened and shaping what happens next.

This is what Panacea was built for. It was built for the gap between prescription and outcome — the space where most people are left without support and where most journeys end too early.

Because the data is unambiguous: support changes outcomes. And right now, most people on GLP-1 therapy don’t have it.

You’ve already done the hard part — you started. Don’t do the rest alone. Join the waitlist for early access to Panacea.